RXRX Deferred Revenue

Recursion Pharmaceuticals Inc Clas · Deferred Revenue

RXRX logo

RXRX Deferred Revenue

Latest reported$37.61M
RXRX FY Deferred Revenue ($0.00 → $37.61M)
High-resolution chart · PNG

RXRX deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Recursion Pharmaceuticals Inc Clas Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
37,605,000
61,767,000
36,426,000
56,726,000
10,000,000
10,000,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.